Skip to main content
Premium Trial:

Request an Annual Quote

Pathway Genomics to Offer Genetic Testing Through Blue Shield of California's PPO Network

NEW YORK (GenomeWeb News) – Pathway Genomics said today it has joined Blue Shield of California's preferred provider network.

The health insurer has more than 3.3 million members, and its HMO has a network of more than 34,000 doctors and 290 hospitals, while its PPO network has more than 60,000 doctors and 351 hospitals.

Last month, San Diego-based Pathway announced a deal to offer its testing services through Medcan Clinic, Canada's largest private healthcare clinic. The Scripps Center for Executive Health also began offering Pathway's testing services this past fall.

Pathway conducts the analysis and interpretation of test results at its CLIA genetic testing lab.

The firm offers several DNA tests covering diet and exercise, drug response, carrier status, and complex health conditions.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.